Two Oral Cancer Drugs Effective in ‘Steve Jobs’ Disease (CME/CE)
(MedPage Today) — Two small-molecule kinase inhibitors appear to be effective at extending progression-free survival in pancreatic neuroendocrine tumors, researchers say.
(MedPage Today) — Two small-molecule kinase inhibitors appear to be effective at extending progression-free survival in pancreatic neuroendocrine tumors, researchers say.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.